Global Organoid Biobank Supply, Demand and Key Producers, 2023-2029
The global Organoid Biobank market size is expected to reach $ 389.7 million by 2029, rising at a market growth of 17.7% CAGR during the forecast period (2023-2029).
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
Organoids refer to three-dimensional tissue structures constructed in vitro through cell engineering, tissue engineering or stem cell technology based on internal organs.
This report studies the global Organoid Biobank demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Organoid Biobank, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Organoid Biobank that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Organoid Biobank total market, 2018-2029, (USD Million)
Global Organoid Biobank total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Organoid Biobank total market, key domestic companies and share, (USD Million)
Global Organoid Biobank revenue by player and market share 2018-2023, (USD Million)
Global Organoid Biobank total market by Type, CAGR, 2018-2029, (USD Million)
Global Organoid Biobank total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Organoid Biobank market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FRANKFURT CANCER INSTITUTE, Merck, Crown Bioscience, HUB Organoids, Cancer Research UK Convergence Science Centre, Thermo Fisher Scientific, Corning, STEMCELL Technologies and Lonza, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Organoid Biobank market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Organoid Biobank Market, By Region:
1. How big is the global Organoid Biobank market?
2. What is the demand of the global Organoid Biobank market?
3. What is the year over year growth of the global Organoid Biobank market?
4. What is the total value of the global Organoid Biobank market?
5. Who are the major players in the global Organoid Biobank market?
The organoid biobank market is a growing field that encompasses the collection, storage, and distribution of human organoid models and biological samples required for a variety of medical and biological research. Key drivers of this market include increased demand for medical research, advances in organ transplantation and drug testing, developments in biotechnology, and the rise of personalized medicine. These biobanks provide researchers and pharmaceutical companies with important resources for disease research, drug screening, and personalized medicine, and therefore have huge potential and market opportunities in the fields of medicine and life sciences.
Organoids refer to three-dimensional tissue structures constructed in vitro through cell engineering, tissue engineering or stem cell technology based on internal organs.
This report studies the global Organoid Biobank demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Organoid Biobank, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Organoid Biobank that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Organoid Biobank total market, 2018-2029, (USD Million)
Global Organoid Biobank total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Organoid Biobank total market, key domestic companies and share, (USD Million)
Global Organoid Biobank revenue by player and market share 2018-2023, (USD Million)
Global Organoid Biobank total market by Type, CAGR, 2018-2029, (USD Million)
Global Organoid Biobank total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Organoid Biobank market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FRANKFURT CANCER INSTITUTE, Merck, Crown Bioscience, HUB Organoids, Cancer Research UK Convergence Science Centre, Thermo Fisher Scientific, Corning, STEMCELL Technologies and Lonza, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Organoid Biobank market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Organoid Biobank Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tissue Derived Organoids
- Pluripotent Stem Cell-derived Organoids
- Biopharmaceutical Companies
- Contract Research Organizations
- Academics and Research Institutes
- FRANKFURT CANCER INSTITUTE
- Merck
- Crown Bioscience
- HUB Organoids
- Cancer Research UK Convergence Science Centre
- Thermo Fisher Scientific
- Corning
- STEMCELL Technologies
- Lonza
- Prellis Biologics
- Amsbio
- Cellesce
- DefiniGEN
- 3Dnamics Inc.
- Organoid Therapeutics
- InSphero
- AIVITA Biomedical
- JangoBio
1. How big is the global Organoid Biobank market?
2. What is the demand of the global Organoid Biobank market?
3. What is the year over year growth of the global Organoid Biobank market?
4. What is the total value of the global Organoid Biobank market?
5. Who are the major players in the global Organoid Biobank market?
1 SUPPLY SUMMARY
1.1 Organoid Biobank Introduction
1.2 World Organoid Biobank Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Organoid Biobank Total Market by Region (by Headquarter Location)
1.3.1 World Organoid Biobank Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Organoid Biobank Market Size (2018-2029)
1.3.3 China Organoid Biobank Market Size (2018-2029)
1.3.4 Europe Organoid Biobank Market Size (2018-2029)
1.3.5 Japan Organoid Biobank Market Size (2018-2029)
1.3.6 South Korea Organoid Biobank Market Size (2018-2029)
1.3.7 ASEAN Organoid Biobank Market Size (2018-2029)
1.3.8 India Organoid Biobank Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Organoid Biobank Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Organoid Biobank Major Market Trends
2 DEMAND SUMMARY
2.1 World Organoid Biobank Consumption Value (2018-2029)
2.2 World Organoid Biobank Consumption Value by Region
2.2.1 World Organoid Biobank Consumption Value by Region (2018-2023)
2.2.2 World Organoid Biobank Consumption Value Forecast by Region (2024-2029)
2.3 United States Organoid Biobank Consumption Value (2018-2029)
2.4 China Organoid Biobank Consumption Value (2018-2029)
2.5 Europe Organoid Biobank Consumption Value (2018-2029)
2.6 Japan Organoid Biobank Consumption Value (2018-2029)
2.7 South Korea Organoid Biobank Consumption Value (2018-2029)
2.8 ASEAN Organoid Biobank Consumption Value (2018-2029)
2.9 India Organoid Biobank Consumption Value (2018-2029)
3 WORLD ORGANOID BIOBANK COMPANIES COMPETITIVE ANALYSIS
3.1 World Organoid Biobank Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Organoid Biobank Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Organoid Biobank in 2022
3.2.3 Global Concentration Ratios (CR8) for Organoid Biobank in 2022
3.3 Organoid Biobank Company Evaluation Quadrant
3.4 Organoid Biobank Market: Overall Company Footprint Analysis
3.4.1 Organoid Biobank Market: Region Footprint
3.4.2 Organoid Biobank Market: Company Product Type Footprint
3.4.3 Organoid Biobank Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Organoid Biobank Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Organoid Biobank Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Organoid Biobank Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Organoid Biobank Consumption Value Comparison
4.2.1 United States VS China: Organoid Biobank Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Organoid Biobank Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Organoid Biobank Companies and Market Share, 2018-2023
4.3.1 United States Based Organoid Biobank Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Organoid Biobank Revenue, (2018-2023)
4.4 China Based Companies Organoid Biobank Revenue and Market Share, 2018-2023
4.4.1 China Based Organoid Biobank Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Organoid Biobank Revenue, (2018-2023)
4.5 Rest of World Based Organoid Biobank Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Organoid Biobank Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Organoid Biobank Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Organoid Biobank Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tissue Derived Organoids
5.2.2 Pluripotent Stem Cell-derived Organoids
5.3 Market Segment by Type
5.3.1 World Organoid Biobank Market Size by Type (2018-2023)
5.3.2 World Organoid Biobank Market Size by Type (2024-2029)
5.3.3 World Organoid Biobank Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Organoid Biobank Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Biopharmaceutical Companies
6.2.2 Contract Research Organizations
6.2.3 Academics and Research Institutes
6.3 Market Segment by Application
6.3.1 World Organoid Biobank Market Size by Application (2018-2023)
6.3.2 World Organoid Biobank Market Size by Application (2024-2029)
6.3.3 World Organoid Biobank Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 FRANKFURT CANCER INSTITUTE
7.1.1 FRANKFURT CANCER INSTITUTE Details
7.1.2 FRANKFURT CANCER INSTITUTE Major Business
7.1.3 FRANKFURT CANCER INSTITUTE Organoid Biobank Product and Services
7.1.4 FRANKFURT CANCER INSTITUTE Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 FRANKFURT CANCER INSTITUTE Recent Developments/Updates
7.1.6 FRANKFURT CANCER INSTITUTE Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Organoid Biobank Product and Services
7.2.4 Merck Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Crown Bioscience
7.3.1 Crown Bioscience Details
7.3.2 Crown Bioscience Major Business
7.3.3 Crown Bioscience Organoid Biobank Product and Services
7.3.4 Crown Bioscience Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Crown Bioscience Recent Developments/Updates
7.3.6 Crown Bioscience Competitive Strengths & Weaknesses
7.4 HUB Organoids
7.4.1 HUB Organoids Details
7.4.2 HUB Organoids Major Business
7.4.3 HUB Organoids Organoid Biobank Product and Services
7.4.4 HUB Organoids Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 HUB Organoids Recent Developments/Updates
7.4.6 HUB Organoids Competitive Strengths & Weaknesses
7.5 Cancer Research UK Convergence Science Centre
7.5.1 Cancer Research UK Convergence Science Centre Details
7.5.2 Cancer Research UK Convergence Science Centre Major Business
7.5.3 Cancer Research UK Convergence Science Centre Organoid Biobank Product and Services
7.5.4 Cancer Research UK Convergence Science Centre Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Cancer Research UK Convergence Science Centre Recent Developments/Updates
7.5.6 Cancer Research UK Convergence Science Centre Competitive Strengths & Weaknesses
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Details
7.6.2 Thermo Fisher Scientific Major Business
7.6.3 Thermo Fisher Scientific Organoid Biobank Product and Services
7.6.4 Thermo Fisher Scientific Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Thermo Fisher Scientific Recent Developments/Updates
7.6.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.7 Corning
7.7.1 Corning Details
7.7.2 Corning Major Business
7.7.3 Corning Organoid Biobank Product and Services
7.7.4 Corning Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Corning Recent Developments/Updates
7.7.6 Corning Competitive Strengths & Weaknesses
7.8 STEMCELL Technologies
7.8.1 STEMCELL Technologies Details
7.8.2 STEMCELL Technologies Major Business
7.8.3 STEMCELL Technologies Organoid Biobank Product and Services
7.8.4 STEMCELL Technologies Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 STEMCELL Technologies Recent Developments/Updates
7.8.6 STEMCELL Technologies Competitive Strengths & Weaknesses
7.9 Lonza
7.9.1 Lonza Details
7.9.2 Lonza Major Business
7.9.3 Lonza Organoid Biobank Product and Services
7.9.4 Lonza Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Lonza Recent Developments/Updates
7.9.6 Lonza Competitive Strengths & Weaknesses
7.10 Prellis Biologics
7.10.1 Prellis Biologics Details
7.10.2 Prellis Biologics Major Business
7.10.3 Prellis Biologics Organoid Biobank Product and Services
7.10.4 Prellis Biologics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Prellis Biologics Recent Developments/Updates
7.10.6 Prellis Biologics Competitive Strengths & Weaknesses
7.11 Amsbio
7.11.1 Amsbio Details
7.11.2 Amsbio Major Business
7.11.3 Amsbio Organoid Biobank Product and Services
7.11.4 Amsbio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Amsbio Recent Developments/Updates
7.11.6 Amsbio Competitive Strengths & Weaknesses
7.12 Cellesce
7.12.1 Cellesce Details
7.12.2 Cellesce Major Business
7.12.3 Cellesce Organoid Biobank Product and Services
7.12.4 Cellesce Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Cellesce Recent Developments/Updates
7.12.6 Cellesce Competitive Strengths & Weaknesses
7.13 DefiniGEN
7.13.1 DefiniGEN Details
7.13.2 DefiniGEN Major Business
7.13.3 DefiniGEN Organoid Biobank Product and Services
7.13.4 DefiniGEN Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 DefiniGEN Recent Developments/Updates
7.13.6 DefiniGEN Competitive Strengths & Weaknesses
7.14 3Dnamics Inc.
7.14.1 3Dnamics Inc. Details
7.14.2 3Dnamics Inc. Major Business
7.14.3 3Dnamics Inc. Organoid Biobank Product and Services
7.14.4 3Dnamics Inc. Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 3Dnamics Inc. Recent Developments/Updates
7.14.6 3Dnamics Inc. Competitive Strengths & Weaknesses
7.15 Organoid Therapeutics
7.15.1 Organoid Therapeutics Details
7.15.2 Organoid Therapeutics Major Business
7.15.3 Organoid Therapeutics Organoid Biobank Product and Services
7.15.4 Organoid Therapeutics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Organoid Therapeutics Recent Developments/Updates
7.15.6 Organoid Therapeutics Competitive Strengths & Weaknesses
7.16 InSphero
7.16.1 InSphero Details
7.16.2 InSphero Major Business
7.16.3 InSphero Organoid Biobank Product and Services
7.16.4 InSphero Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 InSphero Recent Developments/Updates
7.16.6 InSphero Competitive Strengths & Weaknesses
7.17 AIVITA Biomedical
7.17.1 AIVITA Biomedical Details
7.17.2 AIVITA Biomedical Major Business
7.17.3 AIVITA Biomedical Organoid Biobank Product and Services
7.17.4 AIVITA Biomedical Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 AIVITA Biomedical Recent Developments/Updates
7.17.6 AIVITA Biomedical Competitive Strengths & Weaknesses
7.18 JangoBio
7.18.1 JangoBio Details
7.18.2 JangoBio Major Business
7.18.3 JangoBio Organoid Biobank Product and Services
7.18.4 JangoBio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 JangoBio Recent Developments/Updates
7.18.6 JangoBio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Organoid Biobank Industry Chain
8.2 Organoid Biobank Upstream Analysis
8.3 Organoid Biobank Midstream Analysis
8.4 Organoid Biobank Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Organoid Biobank Introduction
1.2 World Organoid Biobank Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Organoid Biobank Total Market by Region (by Headquarter Location)
1.3.1 World Organoid Biobank Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Organoid Biobank Market Size (2018-2029)
1.3.3 China Organoid Biobank Market Size (2018-2029)
1.3.4 Europe Organoid Biobank Market Size (2018-2029)
1.3.5 Japan Organoid Biobank Market Size (2018-2029)
1.3.6 South Korea Organoid Biobank Market Size (2018-2029)
1.3.7 ASEAN Organoid Biobank Market Size (2018-2029)
1.3.8 India Organoid Biobank Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Organoid Biobank Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Organoid Biobank Major Market Trends
2 DEMAND SUMMARY
2.1 World Organoid Biobank Consumption Value (2018-2029)
2.2 World Organoid Biobank Consumption Value by Region
2.2.1 World Organoid Biobank Consumption Value by Region (2018-2023)
2.2.2 World Organoid Biobank Consumption Value Forecast by Region (2024-2029)
2.3 United States Organoid Biobank Consumption Value (2018-2029)
2.4 China Organoid Biobank Consumption Value (2018-2029)
2.5 Europe Organoid Biobank Consumption Value (2018-2029)
2.6 Japan Organoid Biobank Consumption Value (2018-2029)
2.7 South Korea Organoid Biobank Consumption Value (2018-2029)
2.8 ASEAN Organoid Biobank Consumption Value (2018-2029)
2.9 India Organoid Biobank Consumption Value (2018-2029)
3 WORLD ORGANOID BIOBANK COMPANIES COMPETITIVE ANALYSIS
3.1 World Organoid Biobank Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Organoid Biobank Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Organoid Biobank in 2022
3.2.3 Global Concentration Ratios (CR8) for Organoid Biobank in 2022
3.3 Organoid Biobank Company Evaluation Quadrant
3.4 Organoid Biobank Market: Overall Company Footprint Analysis
3.4.1 Organoid Biobank Market: Region Footprint
3.4.2 Organoid Biobank Market: Company Product Type Footprint
3.4.3 Organoid Biobank Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Organoid Biobank Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Organoid Biobank Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Organoid Biobank Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Organoid Biobank Consumption Value Comparison
4.2.1 United States VS China: Organoid Biobank Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Organoid Biobank Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Organoid Biobank Companies and Market Share, 2018-2023
4.3.1 United States Based Organoid Biobank Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Organoid Biobank Revenue, (2018-2023)
4.4 China Based Companies Organoid Biobank Revenue and Market Share, 2018-2023
4.4.1 China Based Organoid Biobank Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Organoid Biobank Revenue, (2018-2023)
4.5 Rest of World Based Organoid Biobank Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Organoid Biobank Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Organoid Biobank Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Organoid Biobank Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tissue Derived Organoids
5.2.2 Pluripotent Stem Cell-derived Organoids
5.3 Market Segment by Type
5.3.1 World Organoid Biobank Market Size by Type (2018-2023)
5.3.2 World Organoid Biobank Market Size by Type (2024-2029)
5.3.3 World Organoid Biobank Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Organoid Biobank Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Biopharmaceutical Companies
6.2.2 Contract Research Organizations
6.2.3 Academics and Research Institutes
6.3 Market Segment by Application
6.3.1 World Organoid Biobank Market Size by Application (2018-2023)
6.3.2 World Organoid Biobank Market Size by Application (2024-2029)
6.3.3 World Organoid Biobank Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 FRANKFURT CANCER INSTITUTE
7.1.1 FRANKFURT CANCER INSTITUTE Details
7.1.2 FRANKFURT CANCER INSTITUTE Major Business
7.1.3 FRANKFURT CANCER INSTITUTE Organoid Biobank Product and Services
7.1.4 FRANKFURT CANCER INSTITUTE Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 FRANKFURT CANCER INSTITUTE Recent Developments/Updates
7.1.6 FRANKFURT CANCER INSTITUTE Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Organoid Biobank Product and Services
7.2.4 Merck Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 Crown Bioscience
7.3.1 Crown Bioscience Details
7.3.2 Crown Bioscience Major Business
7.3.3 Crown Bioscience Organoid Biobank Product and Services
7.3.4 Crown Bioscience Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Crown Bioscience Recent Developments/Updates
7.3.6 Crown Bioscience Competitive Strengths & Weaknesses
7.4 HUB Organoids
7.4.1 HUB Organoids Details
7.4.2 HUB Organoids Major Business
7.4.3 HUB Organoids Organoid Biobank Product and Services
7.4.4 HUB Organoids Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 HUB Organoids Recent Developments/Updates
7.4.6 HUB Organoids Competitive Strengths & Weaknesses
7.5 Cancer Research UK Convergence Science Centre
7.5.1 Cancer Research UK Convergence Science Centre Details
7.5.2 Cancer Research UK Convergence Science Centre Major Business
7.5.3 Cancer Research UK Convergence Science Centre Organoid Biobank Product and Services
7.5.4 Cancer Research UK Convergence Science Centre Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Cancer Research UK Convergence Science Centre Recent Developments/Updates
7.5.6 Cancer Research UK Convergence Science Centre Competitive Strengths & Weaknesses
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Details
7.6.2 Thermo Fisher Scientific Major Business
7.6.3 Thermo Fisher Scientific Organoid Biobank Product and Services
7.6.4 Thermo Fisher Scientific Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Thermo Fisher Scientific Recent Developments/Updates
7.6.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.7 Corning
7.7.1 Corning Details
7.7.2 Corning Major Business
7.7.3 Corning Organoid Biobank Product and Services
7.7.4 Corning Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Corning Recent Developments/Updates
7.7.6 Corning Competitive Strengths & Weaknesses
7.8 STEMCELL Technologies
7.8.1 STEMCELL Technologies Details
7.8.2 STEMCELL Technologies Major Business
7.8.3 STEMCELL Technologies Organoid Biobank Product and Services
7.8.4 STEMCELL Technologies Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 STEMCELL Technologies Recent Developments/Updates
7.8.6 STEMCELL Technologies Competitive Strengths & Weaknesses
7.9 Lonza
7.9.1 Lonza Details
7.9.2 Lonza Major Business
7.9.3 Lonza Organoid Biobank Product and Services
7.9.4 Lonza Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Lonza Recent Developments/Updates
7.9.6 Lonza Competitive Strengths & Weaknesses
7.10 Prellis Biologics
7.10.1 Prellis Biologics Details
7.10.2 Prellis Biologics Major Business
7.10.3 Prellis Biologics Organoid Biobank Product and Services
7.10.4 Prellis Biologics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Prellis Biologics Recent Developments/Updates
7.10.6 Prellis Biologics Competitive Strengths & Weaknesses
7.11 Amsbio
7.11.1 Amsbio Details
7.11.2 Amsbio Major Business
7.11.3 Amsbio Organoid Biobank Product and Services
7.11.4 Amsbio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Amsbio Recent Developments/Updates
7.11.6 Amsbio Competitive Strengths & Weaknesses
7.12 Cellesce
7.12.1 Cellesce Details
7.12.2 Cellesce Major Business
7.12.3 Cellesce Organoid Biobank Product and Services
7.12.4 Cellesce Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Cellesce Recent Developments/Updates
7.12.6 Cellesce Competitive Strengths & Weaknesses
7.13 DefiniGEN
7.13.1 DefiniGEN Details
7.13.2 DefiniGEN Major Business
7.13.3 DefiniGEN Organoid Biobank Product and Services
7.13.4 DefiniGEN Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 DefiniGEN Recent Developments/Updates
7.13.6 DefiniGEN Competitive Strengths & Weaknesses
7.14 3Dnamics Inc.
7.14.1 3Dnamics Inc. Details
7.14.2 3Dnamics Inc. Major Business
7.14.3 3Dnamics Inc. Organoid Biobank Product and Services
7.14.4 3Dnamics Inc. Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 3Dnamics Inc. Recent Developments/Updates
7.14.6 3Dnamics Inc. Competitive Strengths & Weaknesses
7.15 Organoid Therapeutics
7.15.1 Organoid Therapeutics Details
7.15.2 Organoid Therapeutics Major Business
7.15.3 Organoid Therapeutics Organoid Biobank Product and Services
7.15.4 Organoid Therapeutics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Organoid Therapeutics Recent Developments/Updates
7.15.6 Organoid Therapeutics Competitive Strengths & Weaknesses
7.16 InSphero
7.16.1 InSphero Details
7.16.2 InSphero Major Business
7.16.3 InSphero Organoid Biobank Product and Services
7.16.4 InSphero Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 InSphero Recent Developments/Updates
7.16.6 InSphero Competitive Strengths & Weaknesses
7.17 AIVITA Biomedical
7.17.1 AIVITA Biomedical Details
7.17.2 AIVITA Biomedical Major Business
7.17.3 AIVITA Biomedical Organoid Biobank Product and Services
7.17.4 AIVITA Biomedical Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 AIVITA Biomedical Recent Developments/Updates
7.17.6 AIVITA Biomedical Competitive Strengths & Weaknesses
7.18 JangoBio
7.18.1 JangoBio Details
7.18.2 JangoBio Major Business
7.18.3 JangoBio Organoid Biobank Product and Services
7.18.4 JangoBio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 JangoBio Recent Developments/Updates
7.18.6 JangoBio Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Organoid Biobank Industry Chain
8.2 Organoid Biobank Upstream Analysis
8.3 Organoid Biobank Midstream Analysis
8.4 Organoid Biobank Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Organoid Biobank Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Organoid Biobank Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Organoid Biobank Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Organoid Biobank Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Organoid Biobank Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Organoid Biobank Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Organoid Biobank Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Organoid Biobank Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Organoid Biobank Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Organoid Biobank Players in 2022
Table 12. World Organoid Biobank Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Organoid Biobank Company Evaluation Quadrant
Table 14. Head Office of Key Organoid Biobank Player
Table 15. Organoid Biobank Market: Company Product Type Footprint
Table 16. Organoid Biobank Market: Company Product Application Footprint
Table 17. Organoid Biobank Mergers & Acquisitions Activity
Table 18. United States VS China Organoid Biobank Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Organoid Biobank Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Organoid Biobank Companies, Headquarters (States, Country)
Table 21. United States Based Companies Organoid Biobank Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Organoid Biobank Revenue Market Share (2018-2023)
Table 23. China Based Organoid Biobank Companies, Headquarters (Province, Country)
Table 24. China Based Companies Organoid Biobank Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Organoid Biobank Revenue Market Share (2018-2023)
Table 26. Rest of World Based Organoid Biobank Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Organoid Biobank Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Organoid Biobank Revenue Market Share (2018-2023)
Table 29. World Organoid Biobank Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Organoid Biobank Market Size by Type (2018-2023) & (USD Million)
Table 31. World Organoid Biobank Market Size by Type (2024-2029) & (USD Million)
Table 32. World Organoid Biobank Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Organoid Biobank Market Size by Application (2018-2023) & (USD Million)
Table 34. World Organoid Biobank Market Size by Application (2024-2029) & (USD Million)
Table 35. FRANKFURT CANCER INSTITUTE Basic Information, Area Served and Competitors
Table 36. FRANKFURT CANCER INSTITUTE Major Business
Table 37. FRANKFURT CANCER INSTITUTE Organoid Biobank Product and Services
Table 38. FRANKFURT CANCER INSTITUTE Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. FRANKFURT CANCER INSTITUTE Recent Developments/Updates
Table 40. FRANKFURT CANCER INSTITUTE Competitive Strengths & Weaknesses
Table 41. Merck Basic Information, Area Served and Competitors
Table 42. Merck Major Business
Table 43. Merck Organoid Biobank Product and Services
Table 44. Merck Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Merck Recent Developments/Updates
Table 46. Merck Competitive Strengths & Weaknesses
Table 47. Crown Bioscience Basic Information, Area Served and Competitors
Table 48. Crown Bioscience Major Business
Table 49. Crown Bioscience Organoid Biobank Product and Services
Table 50. Crown Bioscience Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Crown Bioscience Recent Developments/Updates
Table 52. Crown Bioscience Competitive Strengths & Weaknesses
Table 53. HUB Organoids Basic Information, Area Served and Competitors
Table 54. HUB Organoids Major Business
Table 55. HUB Organoids Organoid Biobank Product and Services
Table 56. HUB Organoids Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. HUB Organoids Recent Developments/Updates
Table 58. HUB Organoids Competitive Strengths & Weaknesses
Table 59. Cancer Research UK Convergence Science Centre Basic Information, Area Served and Competitors
Table 60. Cancer Research UK Convergence Science Centre Major Business
Table 61. Cancer Research UK Convergence Science Centre Organoid Biobank Product and Services
Table 62. Cancer Research UK Convergence Science Centre Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Cancer Research UK Convergence Science Centre Recent Developments/Updates
Table 64. Cancer Research UK Convergence Science Centre Competitive Strengths & Weaknesses
Table 65. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 66. Thermo Fisher Scientific Major Business
Table 67. Thermo Fisher Scientific Organoid Biobank Product and Services
Table 68. Thermo Fisher Scientific Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Thermo Fisher Scientific Recent Developments/Updates
Table 70. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 71. Corning Basic Information, Area Served and Competitors
Table 72. Corning Major Business
Table 73. Corning Organoid Biobank Product and Services
Table 74. Corning Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Corning Recent Developments/Updates
Table 76. Corning Competitive Strengths & Weaknesses
Table 77. STEMCELL Technologies Basic Information, Area Served and Competitors
Table 78. STEMCELL Technologies Major Business
Table 79. STEMCELL Technologies Organoid Biobank Product and Services
Table 80. STEMCELL Technologies Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. STEMCELL Technologies Recent Developments/Updates
Table 82. STEMCELL Technologies Competitive Strengths & Weaknesses
Table 83. Lonza Basic Information, Area Served and Competitors
Table 84. Lonza Major Business
Table 85. Lonza Organoid Biobank Product and Services
Table 86. Lonza Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Lonza Recent Developments/Updates
Table 88. Lonza Competitive Strengths & Weaknesses
Table 89. Prellis Biologics Basic Information, Area Served and Competitors
Table 90. Prellis Biologics Major Business
Table 91. Prellis Biologics Organoid Biobank Product and Services
Table 92. Prellis Biologics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Prellis Biologics Recent Developments/Updates
Table 94. Prellis Biologics Competitive Strengths & Weaknesses
Table 95. Amsbio Basic Information, Area Served and Competitors
Table 96. Amsbio Major Business
Table 97. Amsbio Organoid Biobank Product and Services
Table 98. Amsbio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Amsbio Recent Developments/Updates
Table 100. Amsbio Competitive Strengths & Weaknesses
Table 101. Cellesce Basic Information, Area Served and Competitors
Table 102. Cellesce Major Business
Table 103. Cellesce Organoid Biobank Product and Services
Table 104. Cellesce Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Cellesce Recent Developments/Updates
Table 106. Cellesce Competitive Strengths & Weaknesses
Table 107. DefiniGEN Basic Information, Area Served and Competitors
Table 108. DefiniGEN Major Business
Table 109. DefiniGEN Organoid Biobank Product and Services
Table 110. DefiniGEN Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. DefiniGEN Recent Developments/Updates
Table 112. DefiniGEN Competitive Strengths & Weaknesses
Table 113. 3Dnamics Inc. Basic Information, Area Served and Competitors
Table 114. 3Dnamics Inc. Major Business
Table 115. 3Dnamics Inc. Organoid Biobank Product and Services
Table 116. 3Dnamics Inc. Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. 3Dnamics Inc. Recent Developments/Updates
Table 118. 3Dnamics Inc. Competitive Strengths & Weaknesses
Table 119. Organoid Therapeutics Basic Information, Area Served and Competitors
Table 120. Organoid Therapeutics Major Business
Table 121. Organoid Therapeutics Organoid Biobank Product and Services
Table 122. Organoid Therapeutics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Organoid Therapeutics Recent Developments/Updates
Table 124. Organoid Therapeutics Competitive Strengths & Weaknesses
Table 125. InSphero Basic Information, Area Served and Competitors
Table 126. InSphero Major Business
Table 127. InSphero Organoid Biobank Product and Services
Table 128. InSphero Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. InSphero Recent Developments/Updates
Table 130. InSphero Competitive Strengths & Weaknesses
Table 131. AIVITA Biomedical Basic Information, Area Served and Competitors
Table 132. AIVITA Biomedical Major Business
Table 133. AIVITA Biomedical Organoid Biobank Product and Services
Table 134. AIVITA Biomedical Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. AIVITA Biomedical Recent Developments/Updates
Table 136. JangoBio Basic Information, Area Served and Competitors
Table 137. JangoBio Major Business
Table 138. JangoBio Organoid Biobank Product and Services
Table 139. JangoBio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Organoid Biobank Upstream (Raw Materials)
Table 141. Organoid Biobank Typical Customers
List of Figure
Figure 1. Organoid Biobank Picture
Figure 2. World Organoid Biobank Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Organoid Biobank Total Market Size (2018-2029) & (USD Million)
Figure 4. World Organoid Biobank Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Organoid Biobank Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 13. Organoid Biobank Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 16. World Organoid Biobank Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 18. China Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 23. India Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Organoid Biobank by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Organoid Biobank Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Organoid Biobank Markets in 2022
Figure 27. United States VS China: Organoid Biobank Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Organoid Biobank Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Organoid Biobank Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Organoid Biobank Market Size Market Share by Type in 2022
Figure 31. Tissue Derived Organoids
Figure 32. Pluripotent Stem Cell-derived Organoids
Figure 33. World Organoid Biobank Market Size Market Share by Type (2018-2029)
Figure 34. World Organoid Biobank Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Organoid Biobank Market Size Market Share by Application in 2022
Figure 36. Biopharmaceutical Companies
Figure 37. Contract Research Organizations
Figure 38. Academics and Research Institutes
Figure 39. Organoid Biobank Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World Organoid Biobank Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Organoid Biobank Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Organoid Biobank Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Organoid Biobank Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Organoid Biobank Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Organoid Biobank Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Organoid Biobank Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Organoid Biobank Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Organoid Biobank Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Organoid Biobank Players in 2022
Table 12. World Organoid Biobank Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Organoid Biobank Company Evaluation Quadrant
Table 14. Head Office of Key Organoid Biobank Player
Table 15. Organoid Biobank Market: Company Product Type Footprint
Table 16. Organoid Biobank Market: Company Product Application Footprint
Table 17. Organoid Biobank Mergers & Acquisitions Activity
Table 18. United States VS China Organoid Biobank Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Organoid Biobank Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Organoid Biobank Companies, Headquarters (States, Country)
Table 21. United States Based Companies Organoid Biobank Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Organoid Biobank Revenue Market Share (2018-2023)
Table 23. China Based Organoid Biobank Companies, Headquarters (Province, Country)
Table 24. China Based Companies Organoid Biobank Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Organoid Biobank Revenue Market Share (2018-2023)
Table 26. Rest of World Based Organoid Biobank Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Organoid Biobank Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Organoid Biobank Revenue Market Share (2018-2023)
Table 29. World Organoid Biobank Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Organoid Biobank Market Size by Type (2018-2023) & (USD Million)
Table 31. World Organoid Biobank Market Size by Type (2024-2029) & (USD Million)
Table 32. World Organoid Biobank Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Organoid Biobank Market Size by Application (2018-2023) & (USD Million)
Table 34. World Organoid Biobank Market Size by Application (2024-2029) & (USD Million)
Table 35. FRANKFURT CANCER INSTITUTE Basic Information, Area Served and Competitors
Table 36. FRANKFURT CANCER INSTITUTE Major Business
Table 37. FRANKFURT CANCER INSTITUTE Organoid Biobank Product and Services
Table 38. FRANKFURT CANCER INSTITUTE Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. FRANKFURT CANCER INSTITUTE Recent Developments/Updates
Table 40. FRANKFURT CANCER INSTITUTE Competitive Strengths & Weaknesses
Table 41. Merck Basic Information, Area Served and Competitors
Table 42. Merck Major Business
Table 43. Merck Organoid Biobank Product and Services
Table 44. Merck Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Merck Recent Developments/Updates
Table 46. Merck Competitive Strengths & Weaknesses
Table 47. Crown Bioscience Basic Information, Area Served and Competitors
Table 48. Crown Bioscience Major Business
Table 49. Crown Bioscience Organoid Biobank Product and Services
Table 50. Crown Bioscience Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Crown Bioscience Recent Developments/Updates
Table 52. Crown Bioscience Competitive Strengths & Weaknesses
Table 53. HUB Organoids Basic Information, Area Served and Competitors
Table 54. HUB Organoids Major Business
Table 55. HUB Organoids Organoid Biobank Product and Services
Table 56. HUB Organoids Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. HUB Organoids Recent Developments/Updates
Table 58. HUB Organoids Competitive Strengths & Weaknesses
Table 59. Cancer Research UK Convergence Science Centre Basic Information, Area Served and Competitors
Table 60. Cancer Research UK Convergence Science Centre Major Business
Table 61. Cancer Research UK Convergence Science Centre Organoid Biobank Product and Services
Table 62. Cancer Research UK Convergence Science Centre Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Cancer Research UK Convergence Science Centre Recent Developments/Updates
Table 64. Cancer Research UK Convergence Science Centre Competitive Strengths & Weaknesses
Table 65. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 66. Thermo Fisher Scientific Major Business
Table 67. Thermo Fisher Scientific Organoid Biobank Product and Services
Table 68. Thermo Fisher Scientific Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Thermo Fisher Scientific Recent Developments/Updates
Table 70. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 71. Corning Basic Information, Area Served and Competitors
Table 72. Corning Major Business
Table 73. Corning Organoid Biobank Product and Services
Table 74. Corning Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Corning Recent Developments/Updates
Table 76. Corning Competitive Strengths & Weaknesses
Table 77. STEMCELL Technologies Basic Information, Area Served and Competitors
Table 78. STEMCELL Technologies Major Business
Table 79. STEMCELL Technologies Organoid Biobank Product and Services
Table 80. STEMCELL Technologies Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. STEMCELL Technologies Recent Developments/Updates
Table 82. STEMCELL Technologies Competitive Strengths & Weaknesses
Table 83. Lonza Basic Information, Area Served and Competitors
Table 84. Lonza Major Business
Table 85. Lonza Organoid Biobank Product and Services
Table 86. Lonza Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Lonza Recent Developments/Updates
Table 88. Lonza Competitive Strengths & Weaknesses
Table 89. Prellis Biologics Basic Information, Area Served and Competitors
Table 90. Prellis Biologics Major Business
Table 91. Prellis Biologics Organoid Biobank Product and Services
Table 92. Prellis Biologics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Prellis Biologics Recent Developments/Updates
Table 94. Prellis Biologics Competitive Strengths & Weaknesses
Table 95. Amsbio Basic Information, Area Served and Competitors
Table 96. Amsbio Major Business
Table 97. Amsbio Organoid Biobank Product and Services
Table 98. Amsbio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Amsbio Recent Developments/Updates
Table 100. Amsbio Competitive Strengths & Weaknesses
Table 101. Cellesce Basic Information, Area Served and Competitors
Table 102. Cellesce Major Business
Table 103. Cellesce Organoid Biobank Product and Services
Table 104. Cellesce Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Cellesce Recent Developments/Updates
Table 106. Cellesce Competitive Strengths & Weaknesses
Table 107. DefiniGEN Basic Information, Area Served and Competitors
Table 108. DefiniGEN Major Business
Table 109. DefiniGEN Organoid Biobank Product and Services
Table 110. DefiniGEN Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. DefiniGEN Recent Developments/Updates
Table 112. DefiniGEN Competitive Strengths & Weaknesses
Table 113. 3Dnamics Inc. Basic Information, Area Served and Competitors
Table 114. 3Dnamics Inc. Major Business
Table 115. 3Dnamics Inc. Organoid Biobank Product and Services
Table 116. 3Dnamics Inc. Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. 3Dnamics Inc. Recent Developments/Updates
Table 118. 3Dnamics Inc. Competitive Strengths & Weaknesses
Table 119. Organoid Therapeutics Basic Information, Area Served and Competitors
Table 120. Organoid Therapeutics Major Business
Table 121. Organoid Therapeutics Organoid Biobank Product and Services
Table 122. Organoid Therapeutics Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Organoid Therapeutics Recent Developments/Updates
Table 124. Organoid Therapeutics Competitive Strengths & Weaknesses
Table 125. InSphero Basic Information, Area Served and Competitors
Table 126. InSphero Major Business
Table 127. InSphero Organoid Biobank Product and Services
Table 128. InSphero Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. InSphero Recent Developments/Updates
Table 130. InSphero Competitive Strengths & Weaknesses
Table 131. AIVITA Biomedical Basic Information, Area Served and Competitors
Table 132. AIVITA Biomedical Major Business
Table 133. AIVITA Biomedical Organoid Biobank Product and Services
Table 134. AIVITA Biomedical Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. AIVITA Biomedical Recent Developments/Updates
Table 136. JangoBio Basic Information, Area Served and Competitors
Table 137. JangoBio Major Business
Table 138. JangoBio Organoid Biobank Product and Services
Table 139. JangoBio Organoid Biobank Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Organoid Biobank Upstream (Raw Materials)
Table 141. Organoid Biobank Typical Customers
List of Figure
Figure 1. Organoid Biobank Picture
Figure 2. World Organoid Biobank Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Organoid Biobank Total Market Size (2018-2029) & (USD Million)
Figure 4. World Organoid Biobank Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Organoid Biobank Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Organoid Biobank Revenue (2018-2029) & (USD Million)
Figure 13. Organoid Biobank Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 16. World Organoid Biobank Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 18. China Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 23. India Organoid Biobank Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Organoid Biobank by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Organoid Biobank Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Organoid Biobank Markets in 2022
Figure 27. United States VS China: Organoid Biobank Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Organoid Biobank Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Organoid Biobank Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Organoid Biobank Market Size Market Share by Type in 2022
Figure 31. Tissue Derived Organoids
Figure 32. Pluripotent Stem Cell-derived Organoids
Figure 33. World Organoid Biobank Market Size Market Share by Type (2018-2029)
Figure 34. World Organoid Biobank Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Organoid Biobank Market Size Market Share by Application in 2022
Figure 36. Biopharmaceutical Companies
Figure 37. Contract Research Organizations
Figure 38. Academics and Research Institutes
Figure 39. Organoid Biobank Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
